Related Experiment Videos

Perioperative statin therapy reduces mortality in normolipidemic patients undergoing cardiac surgery

Muthiah Vaduganathan1, Neil J Stone, Richard Lee

  • 1Division of Cardiac Surgery, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital, Chicago, IL, USA.

The Journal of Thoracic and Cardiovascular Surgery
|September 21, 2010
PubMed

Insights

Perioperative statin therapy significantly reduces mortality in cardiac surgery patients, regardless of baseline cholesterol levels. These findings highlight statins' potential benefits beyond lipid reduction for improved patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Statins are known for lipid reduction but may possess pleiotropic effects.
  • Emerging data suggest statins improve outcomes after coronary artery bypass graft (CABG) surgery.
  • The efficacy of statin therapy in normolipidemic cardiac surgery patients remains unclear.

Purpose of the Study:

  • To investigate the effectiveness of perioperative statin therapy in cardiac surgery patients.
  • To determine if statins offer benefits independent of lipid-lowering effects.
  • To assess the impact of statins on mortality in both hyperlipidemic and normolipidemic patients undergoing cardiac surgery.

Main Methods:

  • A retrospective analysis of 3056 cardiac surgery patients between April 2004 and April 2009.
  • Patients were categorized into four groups based on hyperlipidemia (HL) and perioperative statin use (statin-untreated vs. statin-treated).
  • Adjusted hazard ratios were calculated, accounting for preoperative cardiac risk factors; mortality was tracked via database review and the Social Security Death Index.

Main Results:

  • Perioperative statin therapy was associated with a significant reduction in 30-day and overall all-cause mortality across groups.
  • Specifically, statin-treated normolipidemic (NL+) patients had 0% 30-day mortality and 3.9% overall mortality.
  • Statin therapy for normolipidemic patients independently reduced overall all-cause mortality (adjusted hazard ratio: 0.34; P = .004).

Conclusions:

  • Perioperative statin therapy is linked to reduced mid-term mortality in cardiac surgery patients.
  • These benefits appear consistent irrespective of the patient's baseline lipid status.
  • The findings suggest that statins' beneficial effects may extend beyond their lipid-lowering capabilities.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...